Dermata TherapeuticsDRMA
13F holders, Q3 2025 (September 30)5holders
$5.02avg. 13F price*
At the end of Q3 2025, 5 institutions reported holding Dermata Therapeutics Inc. (DRMA) in their 13F filings. The largest holders were Armistice Capital, LLC ($410K), UBS Group AG ($50K) and Tower Research Capital LLC (TRC) ($2K).
- Company
- Dermata Therapeutics Inc.
- CUSIP
- 249845504
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
No earlier quarter to compare with.
Ownership 5 holders
| Armistice Capital, LLC | 0.01% | Add +129.4% | 81,654 | $410K |
| UBS Group AG | 0.00% | No change | 10,047 | $50K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -27.5% | 426 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -9.5% | 101 | $507 |
| Bank of America Corp. | 0.00% | Add +16.8% | 4 | $20 |
"% of holder's portfolio" is DRMA's weight in each manager's 13F, not the share of Dermata Therapeutics Inc. the manager owns.